• 中文版
  • Home
  • About Us
    • Contract Research Organization
    • Contract Development and Manufacturing Organization
    • Accolades
    • Publications
  • Services Overview
  • Discovery Chemistry
    • Synthetic Chemistry
    • Medicinal Chemistry
    • Library Chemistry
    • Peptide Chemistry
    • Fragment Based Screening
    • Computer Aided Drug Design
    • Analytical Services
    • Protein Structure
  • Biology & Pharmacology
    • Oncology
    • Pathology Core Facility
    • Immunology
    • Tumor Immunology
    • Neuroscience
    • Cell Biology
    • In Vitro Biology
      • Kinases
      • Epigenetics
      • GPCR, NR, Ion-channel, Transporter
      • Ubiquitin & PROTAC
      • KRAS
      • COVID-19
      • Radiometric
      • Customized assay development
      • High throughput screening
      • MOA Study
    • Metabolic & Cardiovascular Diseases
  • DMPK / Exploratory Toxicology
    • DMPK / Exploratory Toxicology
    • Biomarkers, Preclinical & Clinical Sample Bioanalysis
    • Large molecule PK/BA services
  • Biologics Discovery
    • Antibody Discovery
    • Protein Science
    • Biologics Analytical Services
    • B Cell Cloning
  • Biologics CMC
    • Stable Cell Line Development
    • Process Development
    • Formulation Development
    • Aseptic Filling and Freeze-drying
    • Drug Developability / Manufacturability study
    • Final Container Extractables & Leachables Study
    • Analytical Development and Testing
    • GMP Production
  • Small Molecule CMC
    • Process R&D Services
    • Process Safety
    • Analytical Development
    • Pre-Formulation Development
    • Formulation Development
    • ICH Stability Studies
    • CMC CTD Support
    • Manufacturing
  • Blog
  • Careers
  • News & Events
    • Webinars
  • Contact Us
  • Download Center

Call us today! +86 21 5132 0088

contact@chempartner.com
中文版
Shanghai ChemPartner Shanghai ChemPartner Shanghai ChemPartnerShanghai ChemPartner
  • Home
  • About Us
    • About ChemPartner
    • CRO
    • CDMO
    • Accolades
    • Publications
  • Services
    • Discovery Chemistry
      • Synthetic Chemistry
      • Medicinal Chemistry
      • Library Chemistry
      • Peptide Chemistry
      • Fragment Based Screening
      • Computer Aided Drug Design
      • Analytical Services
      • Protein Structure
    • Biology & Pharmacology
      • Oncology
      • Pathology Core Facility
      • Immunology
      • Tumor Immunology
      • Cell Biology
      • In Vitro Biology
      • Neuroscience
      • Metabolic & Cardiovascular Diseases
      • Epigenetics
    • DMPK / Exploratory Toxicology
      • DMPK / Exploratory Toxicology
      • Biomarkers, Preclinical & Clinical Sample Bioanalysis
      • Large molecule PK/BA services
    • Biologics Discovery
      • Antibody Discovery
      • Protein Science
      • Biologics Analytical Services
      • B Cell Cloning
    • Biologics CMC
      • Stable Cell Line Development
      • Process Development
      • Formulation Development
      • Aseptic Filling and Freeze-drying
      • Drug Developability / Manufacturability study
      • Final Container Extractables & Leachables Study
      • Analytical Development and Testing
      • GMP Production
    • Small Molecule CMC
      • Process R&D Services
      • Process Safety
      • Analytical Development
      • Pre-Formulation Development
      • Formulation Development
      • ICH Stability Studies
      • CMC CTD Support
      • Manufacturing
  • Blog
  • Careers
  • News & Events
    • Webinars
  • Contact Us
  • Download Center

Peptides

Home Introduction Peptides

The Peptide leadership at ChemPartner San Francisco offers a unique blend of US based project team leadership with the cost effective backing of a 30+ strong Peptide chemistry group located in Shanghai, China.  Our projects are truly partnered with biotech and pharmaceutical clients, both large and small, to advance therapeutic candidates. The ChemPartner team excels in combining peptide design and synthesis efforts to drive projects forward and efficiently deliver on client specified  design goals and project timelines.  Multiple client projects have been successfully executed through the CP-SF and Shanghai based Peptides blended team.

  • The US based Peptide leadership offers:
    • Leaders with > 20 years of experience leading therapeutic peptide discovery programs at US based biotech and pharmaceutical companies
    • Expertise in peptide chemistry, including solid phase and liquid phase peptide synthesis, peptide conjugates and peptidomimetics, as well as new bioconjugation techniques
    • Efficient collaboration between US and Shanghai team to thoroughly review data, troubleshoot technical issues and deliver results with data driven recommendations on strategy and path forward
    • Strong and open lines of communication in all directions: with clients, Shanghai based team leaders and scientists
    • Biweekly project team meetings, slide presentations and access to up to date project status and availability for discussions during normal business hours in North America
    • Fully equipped Biotage Syro II parallel peptide synthesizer with heating & inert gas
    • Supporting purification and analytical capability for synthetic route scouting and method development for efficient method transfer to Shanghai team
    • Peptide Design and Synthesis Support Capabilities including:
      • Peptide Design in SF coupled with Computational design in SF and Shanghai
      • Peptide Drug Design and Stabilization
      • Lead Optimization
      • Solubility testing
      • Client Consultation on Project Scoping
      • Feasibility Studies
      • Synthesis method development
      • Process Development and Scaleup
  • The Shanghai based Peptide team offers:
    • 2 Biotage Syro II parallel peptide synthesizers to enable small and large library syntheses
    • Strong group leadership with > 20 years experience in peptide synthesis, characterization and conjugation combined with strong building block synthesis skills
    • Peptide Synthesis Expertise:
      • Macrocycles & macrocycle libraries
      • Multiple disulfide bridged peptides
      • Hydrocarbon bridge “stapled” peptides
      • 1,2,3-Triazole cyclic or bridged peptides via click reaction
      • Novel linker synthesis & novel peptide backbone modifications
      • N-and C-terminal and side-chain modifications
      • Unnatural amino acid building blocks synthesis and peptide incorporation
      • Labeled peptides
      • Peptide conjugates
      • Cyclic peptides
      • Peptide libraries
    • Peptide Synthesis Capabilities:
      • Peptide synthesis scale: up to 5 g
      • Unnatural amino acid building blocks synthesis scale: up to 20 g
      • MW range: up to 100 amino acids
      • Purity: 85 % – 99 % as needed by client
      • Salt exchange
      • Circular Dichroism for % helicity determination
      • QC: LCMS (identity) and RP-HPLC (purity)
      • AAA, nitrogen content, salt content, water content upon request
      • Timeline: 2-3 weeks for standard synthesis or small library production; 1-2 weeks additional for synthesis or purification method development work
    • Fully equipped peptide synthesis, purification and characterization capabilities including:
      • 2 Biotage Syro II parallel peptide synthesizers to enable small and large library syntheses
      • 2 Waters Autopure mass directed purification systems and 1 UV-driven system
      • Other supporting purification and analytical capability for complex library support
      • Access to Triple TOF 5600 and QE mass spectrometers
      • COA including LCMS and HPLC characterization of all synthesized peptides
  • Service Overview
  • Discovery Chemistry
    • Synthetic Chemistry
    • Medicinal Chemistry
    • Library Chemistry
    • Peptide Chemistry
    • Fragment Based Screening
    • Computer Aided Drug Design
    • Analytical Services
    • Protein Structure
  • Biology & Pharmacology
    • Oncology
      • OncoCP Database
    • Pathology Core Facility
      • Histopathology
      • Molecular Pathology
    • Immunology
      • Primary immune cell assays
      • Immune cell line assays
      • Autoimmune disease models
      • In vivo PD models
      • Immune profiling for MOA
    • Tumor Immunology
    • Neuroscience
      • Volume Discount Fast services for Neuroscience
      • Behavioral Pharmacology
      • In vivo Pain Models
      • Non-Human Primate Cognition
      • In Vitro Electrophysiology
    • Cell Biology
      • Target Validation
      • Cell-based Assays
      • Cancer Cell Line Panel Screen
      • Biomarker Analysis
    • In Vitro Biology
      • Kinases
      • Epigenetics
      • GPCR, NR, Ion-channel, Transporter
      • Ubiquitin & PROTAC
      • KRAS
      • COVID-19
      • Radiometric
      • Customized assay development
      • High throughput screening
      • MOA Study
    • Metabolic & Cardiovascular Diseases
  • DMPK / Exploratory Toxicology
    • DMPK / Exploratory Toxicology
      • In vitro ADME
      • Pharmacokinetics
      • Exploratory Toxicology
      • Bioanalysis
      • Regulatory filing
    • Biomarkers, Preclinical & Clinical Sample Bioanalysis
    • Large molecule PK/BA services
      • Monoclonal Antibodies
      • Antibody Drug Conjugates
      • Bispecific Antibodies
      • Proteins & Peptides
      • Immunogenicity
  • Biologics Discovery
    • Antibody Discovery
      • Hybridoma
      • Antibody Engineering
      • Phage Display
      • Antibody-Drug Conjugate
    • Protein Science
    • Biologics Analytical Services
      • mAb Release Tests and Extended Characterization
      • Antibody-Drug Conjugate(ADC) Analysis
      • Therapeutic Protein Characterization
      • Biomolecular Interaction Analysis
    • B Cell Cloning
  • Biologics CMC
    • Stable Cell Line Development
    • Process Development
    • Formulation Development
    • Aseptic Filling and Freeze-drying
    • Drug Developability / Manufacturability study
    • Final Container Extractables & Leachables Study
    • Analytical Development and Testing
    • GMP Production
  • Small Molecule CMC
    • Process R&D Services
    • Process Safety
    • Analytical Development
    • Pre-Formulation Development
    • Formulation Development
    • ICH Stability Studies
    • CMC CTD Support
    • Manufacturing

Give us a Message

You can leave us a message by quick contact box and we'll get back to you, asap. Thanks!

Send Message

Logo

ChemPartner is a leading research organization providing high-quality and cost-effective services for the pharmaceutical and biotechnology industry.

Get started today.

Contact Us
  • Shanghai ChemPartner Co., Ltd.
  • 1F & 3F, Block A, 2829 JinKe Road, Zhangjiang Hi-Tech Park, PuDong New Area, Shanghai China, 201203
  • +86 21 5132 0088
  • contact@chempartner.com

© 2021 — Shanghai ChemPartner Co., Ltd. All Rights Reserved  About Us  Careers  Contact Us  Privacy Policy  Sitemap

  • Home
  • Contact
  • Buy Highend